Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2015-07-28 | veltuzumab | Immunomedics (USA - NJ) | immune thrombocytopenic purpura |
Granting of the orphan status in the US |
2015-09-10 | tipelukast | MediciNova (USA - CA) | idiopathic pulmonary fibrosis |
Granting of a Fast Track status |
2012-01-23 | MOR202 (anti CD38 antibody) | Morphosys (Germany) | Granting of a patent | |
2015-03-31 | emixustat hydrochloride | Acucela (USA - WA) | age-related macular degeneration |
Granting of a patent |
2017-04-20 | rolapitant | Tesaro (USA - MA) OPKO Health (USA - FL) | prevention of chemotherapy-induced nausea and vomiting (CINV) | Granting of a Market Authorisation in the EU |
2015-10-02 | ambrisentan and tadalafil | Gilead Sciences (USA - CA) | pulmonary arterial hypertension (PAH) |
Granting of a Market Authorisation in the US |
2015-02-16 | coronary balloon catheter | Medtronic (USA - MN) | Product launch | |
2015-10-12 | Medtronic (Ireland) | spine surgery |
Granting of a Market Authorisation in the US | |
2015-10-12 | diagnostic test | LabCorp (USA - NC) | patients with previously-treated non-small cell lung cancer (NSCLC) |
Product launch |
2015-08-10 | lyso-thermosensitive liposomal doxorubicin (LTLD) | Celsion (USA - NJ) | hepatocellular carcinoma |
Granting of a patent |
2015-09-29 | adeno-associated virus vector serotype 9 expressing human a-L-iduronidase | RegenXBio (USA - MD) | mucopolysaccharidosis type I (MPS I) |
Granting of the orphan status in the US |
2015-10-13 | C1 esterase inhibitor | Shire (UK - USA) |
|
Granting of a Fast Track status |
2015-06-01 | expression platform | CEVEC Pharmaceuticals (Germany) | Product launch | |
2015-09-07 | expression platform | CEVEC Pharmaceuticals (Germany) | Granting of a patent | |
2015-05-11 | selective inhibitors of IKK-epsilon and TBK1 | Domainex (UK) | Granting of a patent | |
2015-09-14 | masitinib | AB Science (France) | gastric cancer including cancer of the gastroesophageal junction |
Granting of the orphan status in the US |
2015-05-25 | masitinib | AB Science (France) | asthma |
Granting of a patent |
2015-10-08 | Delcath Systems (USA - NY) | Reimbursement | ||
2014-11-19 | olaptesed pegol | Noxxon Pharma (Germany) | glioma |
Granting of the orphan status in the EU |
2015-06-09 | self-delivering RNAi platform (sd-rxRNA®) | RXi Pharmaceuticals (USA - MA) | Granting of a patent |
© 2024 Biopharmanalyses - Powered by Samacom+